J.E. Osborne

Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma.

P E Hutchinson, J.E. Osborne, John T. Lear et al. · PubMed · 2000 · 181 citations

Medicine, Melanoma, Immunology +13

A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision

J.E. Osborne, P.E. Hutchinson · British Journal of Plastic Surgery · 2002 · 142 citations

Surgical Oncology, Follow-up Study, Surgical Pathology +6

An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous malignant melanoma

M.F. HEALSMITH, J.F. BOURKE, J.E. Osborne et al. · British Journal of Dermatology · 1994 · 124 citations

Abcde Checklist, Diagnosis, Pathology +18

A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma

John A. Halsall, J.E. Osborne, L. Potter et al. · British Journal of Cancer · 2004 · 103 citations · Full text

Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis

John A. Halsall, J.E. Osborne, James H. Pringle et al. · Pharmacogenetics and Genomics · 2005 · 76 citations